PATENT CLAIM ANALYSIS

Application Number: 15893396
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "455000"]

Abstract:
The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.

Claim (Index 24):
The formulation of  claim 1  wherein the enteric or delayed release coating comprises shellac (esters of aleurtic acid), cellulose acetate phthalate (CAP), poly(methacrylic acid-co-methyl methacrylate), cellulose acetate trimellitate (CAT), poly(vinyl acetate phthalate) (PVAP), hydroxypropyl methylcellulose phthalate (HPMCP), plant fibers, plastics, hydroxypropylmethylcellulose, hydroxypropylcellulose, methacrylic acid: methacrylate copolymers, aminoalkyl methacrylate copolymers, cellulose acetate, triacetin, triethylcitrate, polyols such as glycerol, propylene glycol, polyethylene glycols PEG or organic esters such as phthalate esters (diethyl, dibutyl), citrate esters (triethyl, acetyl triethyl, acetyl tributyl), or oils/glycerides, acetylated monoglycerides or fractionated coconut oil or combinations thereof.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14211659', '11846896', '13052798', '13719640', '13657135']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589137124109594
- 35 USC 102 Novelty (BERT): 0.5044264062627033
- Combined Prediction Score: 0.7334649817961338
- Mean Citation Score: 263.475926
- Max Citation Score: 274.77957000000004
- Similarity Product: 211.1168769818491

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test